PD Dr. Markus Hecht



Organisationseinheit


Strahlenklinik


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 5 Go to next page Go to last page

Hecht, M., Donaubauer, A., Becker, I., Rutzner, S., Lubgan, D., Lettmaier, S.,... Frey, B. (2019). Complete Remission with consecutive Pneumonitis in metastatic Bronchogenic Carcinoma after combination of Radiotherapy and Nivolumab - Immunological Correlate in peripheral Blood. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S158-S158). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Lettmaier, S., Hecht, M., & Fietkau, R. (2019). First Erlang Experience with Durvalumab Maintenance Therapy after definitive Radiochemotherapy in Patients with NSCLC. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S73-S73). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Jost, T., Hecht, M., Fietkau, R., & Distel, L. (2019). Influence of the Kinase Inhibitor Palbociclib on the Migration of malignant and non-malignant Cells under Irradiation. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S171-S171). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Onbasi, Y., Lettmaier, S., Hecht, M., Semrau, S., Iro, H., Kesting, M.R.,... Haderlein, M. (2019). Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? Strahlentherapie und Onkologie, 195(6), 482-495. https://dx.doi.org/10.1007/s00066-018-1415-y
Onbasi, Y., Lettmaier, S., Hecht, M., Semrau, S., Iro, H., Kesting, M.R.,... Haderlein, M. (2019). Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? Strahlentherapie und Onkologie, 195(6), 482-495. https://dx.doi.org/10.1007/s00066-018-1415-y
Echarti, A., Hecht, M., Fietkau, R., & Distel, L. (2019). Prognostic Importance of the CD8-based Immune Status Inflamed, immune-Excluded, and immune Desert in Head and Neck Cancer Patients can be further subdivided by regulatory T Cells. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S44-S44). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Fietkau, R., Hecht, M., Hofner, B., Iro, H., Gefeller, O., Roedel, C.,... Balermpas, P. (2019). Radiotherapy with paclitaxel/cisplatin vs. fluorouracil/cisplatin for head and neck cancer. In RADIOTHERAPY AND ONCOLOGY (pp. S194-S194). Milan, IT: CLARE: ELSEVIER IRELAND LTD.
Haderlein, M., Scherl, C., Semrau, S., Lettmaier, S., Hecht, M., Putz, F.,... Fietkau, R. (2019). Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin - High locoregional control rates after photon (chemo) radiotherapy - Experience from a monocentric analysis. Radiation Oncology, 14(1). https://dx.doi.org/10.1186/s13014-019-1260-x
Hecht, M., Hahn, D., Wolber, P., Hautmann, M., Reichert, D., Weniger, J.,... Fietkau, R. (2018). Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study. In ANNALS OF ONCOLOGY. Munich, DE: OXFORD: OXFORD UNIV PRESS.
Hecht, M., Meier, F., Zimmer, L., Polat, B., Loquai, C., Weishaupt, C.,... Heinzerling, L. (2018). Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients. British Journal of Cancer, 118(6), 785-792. https://dx.doi.org/10.1038/bjc.2017.489

Zuletzt aktualisiert 2019-16-05 um 23:51